期刊文献+

依达拉奉凝胶的制备及体外透皮性能研究 被引量:2

Preparation and in Vitro Permeation of Edaravone Gel
原文传递
导出
摘要 目的考察依达拉奉凝胶体外经皮渗透性,筛选凝胶剂最佳处方。方法采用Valin-Chien双室渗透扩散池,以大鼠离体皮肤为渗透屏障,以HPLC测定依达拉奉的浓度,考察含药量、月桂氮?酮用量、环糊精的型号和含量对依达拉奉凝胶剂经皮渗透性的影响。结果凝胶剂最佳处方为6%依达拉奉、10%月桂氮?酮、10%β-环糊精、2%羧甲基纤维素钠,依达拉奉12 h累积渗透量平均值为(501.95±27.59)μg·cm?2,渗透速率平均值为(42.25±7.39)μg·cm?2·h?1。结论依达拉奉凝胶剂具有较好的经皮渗透特性,有望成为新的给药制剂。 OBJECTIVE To prepare edaravone transdermal gel and to study its permeation ability in vitro. METHODS The skin permeation ability was evaluated by Valian-Chien permeation cells with isolated rat skin. The concentration of edaravone in samples was determined by HPLC to study the effect of different drug content, laurocapram amount, type and content of the cyclodextrin. RESULTS The optimal form ulation was composed with 6% edaravone, 10% laurocapram, 10% β-cyclodextrin, and 2% sodium carboxymethyl cellulose. The accumulative permeation amount of the gel was(501.95±27.59)μg·cm^-2 in 12 h, and the permeation rate was(42.25±7.39)μg·cm^-2·h^-1. CONCLUSION Edaravone gel prepared in the study would be developed as a novel transdermal preparation.
出处 《中国现代应用药学》 CAS CSCD 2016年第6期752-755,共4页 Chinese Journal of Modern Applied Pharmacy
基金 浙江省医学会临床科研基金项目(2013ZYC-A133) 台州恩泽医疗中心(集团)科研基金项目(14EZD1)
关键词 依达拉奉 凝胶 环糊精 月桂氮䓬酮 经皮渗透 edaravone gel cyclodextrin laurocapram transdermal permeation
  • 相关文献

参考文献2

二级参考文献29

  • 1钟华,尹蓉莉,谢秀琼,周淑芳,文登福,袁龙,陈金玉.莪术微乳凝胶的成型工艺研究[J].华西药学杂志,2010,25(5):523-526. 被引量:6
  • 2TIAN Q, REN F, XU Z, et al. Preparation of high solubilizable microemulsion of naproxen and its solubilization mechanism [J]. Int J Pharm, 2012, 426 (1/2): 202-210.
  • 3SHEN L N, ZHANG Y T, WANG Q, et al. Preparation and evaluation of microemulsion-based transdermal delivery of total flavone of rhizoma arisaematis [J]. Int J Nanomedicine, 2014, 22(9): 3453-3464.
  • 4CUI F D.r Pharmacy(药剂学)[M]. Vol 7. Beijing: People's Medical Publishing House, 2013: 296-298.
  • 5MOGHIMIPOUR E, SALIMI A, EFTEKHARI S. Design and characterization ofmicroemulsionsystems for naproxen [J]. Adv Pharm Bull, 2013, 3(1): 63-71.
  • 6NEGRO E, LATSUZBAIA R, DEVRIES A H, et al. Experimental and molecular dynamics characterization of dense microemulsion systems: morphology, conductivity and SAXS [J]. Soft Matter, 2014, 10(43): 8685-8697.
  • 7NIKUMBH K V, SEVANKAR S G, PATIL M P. Formulation development, in vitro and in vivo evaluation of microemulsion- based gel loaded with ketoprofen [J]. Drug Deliv, 2013. Doi: 10.3109/10717544.2013.859186.
  • 8XUAN X Y, CHENG Y L, ACOSTA E. Lecithin-linker microemulsion gelatin gels for extended drug delivery [J]. Pharmaceutics, 2012,4(1): 104-129.
  • 9DJEKIC L, PRIMORAC M, FILIPIC S, et al. Investigation of surfactant/cosurfactant synergism impact on ibuprofen solubilization capacity and drug release characteristics of nonionic microemulsions [J]. Int J Pharm, 2012, 433(1/2): 25-33.
  • 10SHAMMA R N, ELSAYED I. Transfersomal lyophilized gel of buspirone HCI: formulation, evaluation and statistical optimization [J]. J Liposome Res, 2013, 23(3): 244-254.

共引文献35

同被引文献5

引证文献2

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部